Condition (MeSH)
Hypertensive Retinopathy
ClinicalTrials.gov lists 7 trials for Hypertensive Retinopathy or a narrower condition beneath it. Data Yakka, Inc. has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
5 of the 7 trials are tagged with Hypertensive Retinopathy itself; the rest are tagged with a narrower condition beneath it.
When did Hypertensive Retinopathy trials start? (6)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 3
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 1 |
| 2021 | 2 |
| 2015 | 1 |
| 2014 | 1 |
| 2013 | 1 |
| 2010 | 1 |
No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 7 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Hypertensive Retinopathy trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 1 |
| Not applicable | 1 |
| Observational | 5 |
How many Hypertensive Retinopathy trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 2 |
| Completed | 2 |
| Terminated | 1 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Hypertensive Retinopathy trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Data Yakka, Inc. | 1 |
Which publications cover Hypertensive Retinopathy? (10)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Associations between brachial-ankle pulse wave velocity and hypertensive retinopathy in treated hypertensive adults: Results from the China Stroke Primary Prevention Trial (CSPPT). | Journal of clinical hypertension (Greenwich, Conn.) | 2024 | Yes |
| Impact of Arterial Hypertension on the Eye: A Review of the Pathogenesis, Diagnostic Methods, and Treatment of Hypertensive Retinopathy. | Medical science monitor : international medical journal of experimental and clinical research | 2022 | Yes |
| Association between retinopathy and cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC] Study). | The American journal of cardiology | 2012 | Yes |
| Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study. | Archives of ophthalmology (Chicago, Ill. : 1960) | 2012 | Yes |
| MicroRNAs are involved in end-organ damage during hypertension. | Hypertension (Dallas, Tex. : 1979) | 2012 | Yes |
Showing 5 of 10 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, and rare-disease identity.
Not computed for conditions with fewer than 10 trials: drugs tested.